# LENZ Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Sep 22, 2025

- Company: [LENZ Therapeutics, Inc.](/companies/lenz.md) (CIK 1815776)
- Form: SCHEDULE 13D/A
- Filed: 2025-09-22
- Accepted by EDGAR: Sep 22, 2025, 16:20 ET
- Period: not reported
- Accession: 0001193125-25-211357
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1815776/000119312525211357/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1815776/000119312525211357/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1815776/000119312525211357/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Sep 22, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-211357. Last ingested by Listed: Nov 5, 2026, 13:56 ET. No prices; not investment advice.